Here's the live share price of Godavari Drugs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Godavari Drugs has gained 18.18% CAGR. Over the past year, the corresponding return has been -28.82%.
Godavari Drugs’s current P/E of 16.87x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Godavari Drugs | 10.81 | 7.27 | -1.9 | -11.2 | -28.66 | -2.36 | 18.23 |
| Sun Pharmaceutical Industries | -1.5 | -2.97 | 5.6 | 2.92 | -6.64 | 19.85 | 23.95 |
| Divi's Laboratories | 0.59 | 0.05 | 8.81 | -2.53 | 9.14 | 23.21 | 11.26 |
| Torrent Pharmaceuticals | 1.71 | 2.1 | 8.24 | 18.54 | 11.91 | 34.57 | 22.34 |
| Cipla | 0.26 | -0.27 | -0.45 | -0.46 | 0.93 | 11.09 | 12.61 |
| Dr. Reddy's Laboratories | -0.82 | 2.68 | -0.45 | -5.35 | -6.35 | 14.32 | 4.04 |
| Lupin | -0.81 | 2.79 | 7.11 | 8.57 | -3.69 | 41.44 | 16.38 |
| Zydus Lifesciences | -0.21 | -1.68 | -10.5 | -6.46 | -4.96 | 29.44 | 13.34 |
| Mankind Pharma | 2.36 | -2.21 | -12.95 | -4.99 | -24.71 | 15.49 | 9.03 |
| Aurobindo Pharma | -0.33 | -0.13 | 9.95 | 7.66 | -3.98 | 40.24 | 5.84 |
| Alkem Laboratories | 0.11 | -3.06 | 0.38 | 13.87 | 2.21 | 21.49 | 13.67 |
| Abbott India | 3.58 | -4.63 | -4.44 | -8.9 | 0.83 | 9.88 | 12.95 |
| Laurus Labs | 6.73 | 10.57 | 20.94 | 61.78 | 89.82 | 41.57 | 25.53 |
| Glenmark Pharmaceuticals | 3.09 | 7.11 | -0.78 | 17.45 | 30.78 | 67.89 | 32.23 |
| Biocon | 0.8 | 0.55 | 11.09 | 12.43 | 14.1 | 14.25 | -3.23 |
| GlaxoSmithKline Pharmaceuticals | -3.62 | -1.12 | -9.98 | -24.61 | 9.73 | 22.76 | 8.76 |
| Anthem Biosciences | -2.6 | 2.76 | -18.98 | -10.8 | -10.8 | -3.74 | -2.26 |
| Ipca Laboratories | 1.58 | 1.92 | 6.12 | 5.53 | -10.09 | 19.1 | 5.77 |
| Ajanta Pharma | 3.14 | 6.93 | 7.95 | 3.81 | -4.03 | 31.35 | 18.99 |
| J B Chemicals & Pharmaceuticals | 1.58 | 2.5 | 8.62 | 1.06 | 0.33 | 23.21 | 28.62 |
Over the last one year, Godavari Drugs has declined 28.66% compared to peers like Sun Pharmaceutical Industries (-6.64%), Divi's Laboratories (9.14%), Torrent Pharmaceuticals (11.91%). From a 5 year perspective, Godavari Drugs has outperformed peers relative to Sun Pharmaceutical Industries (23.95%) and Divi's Laboratories (11.26%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 77.31 | 79.45 |
| 10 | 74.69 | 77.3 |
| 20 | 74.63 | 76.59 |
| 50 | 79.38 | 78.65 |
| 100 | 81.82 | 81.91 |
| 200 | 87.57 | 87.34 |
In the latest quarter, Godavari Drugs saw a drop in promoter holding to 52.61%, while DII stake unchanged at 0.50%, FII holding unchanged at 0.00%, and public shareholding moved up to 46.90% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Nov 14, 2025, 9:48 PM IST | Godavari Drugs - Unaudited Financials Results Pursuant To Regulation 33 Of The SEBI(LODR) Regulations, 2015 For The Quarter A |
| Nov 14, 2025, 9:40 PM IST | Godavari Drugs - Board Meeting Outcome for Unaudited Financial Statement For The Half-Year Ended 30Th September 2025 |
| Nov 07, 2025, 10:11 PM IST | Godavari Drugs - Board Meeting Intimation for Notice Of Board Meeting Scheduled To Be Held On Friday, November 14, 2025. |
| Oct 08, 2025, 9:08 PM IST | Godavari Drugs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 30, 2025, 12:20 AM IST | Godavari Drugs - Scrutinizer''''s Report |
Godavari Drugs Ltd. is a Public Limited Listed company incorporated on 02/12/1987 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1987PLC008016 and registration number is 008016. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 113.35 Cr. and Equity Capital is Rs. 7.53 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Godavari Drugs is ₹82.93 as on Dec 26, 2025.
The Godavari Drugs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Godavari Drugs is ₹62.45 Cr as on Dec 26, 2025.
Today’s highest and lowest price of Godavari Drugs are ₹86.00 and ₹81.50.
The 52-week high/low is the highest and lowest price at which Godavari Drugs stock has traded in the past 52-week or nearly a year. The 52-week high of Godavari Drugs is ₹120.95 and 52-week low of Godavari Drugs is ₹69.70 as on Dec 26, 2025.
The Godavari Drugs has shown returns of 1.19% over the past day, 7.04% for the past month, -2.12% over 3 months, -28.82% over 1 year, -2.43% across 3 years, and 18.18% over 5 years.
P/E ratio of and PB ratio of Godavari Drugs are 16.87 and 1.38 on Dec 26, 2025. While the company gives a dividend yield of 0.00 per annum.